Condition
Follicular Lymphoma Grade 3 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Follicular Lymphoma Grade 3 clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
XNW5004 tablets for relapsed or refractory EZH2 wild-type follicular lymphoma
This trial will try XNW5004 tablets in adults with relapsed or refractory EZH2 wild-type follicular lymphoma who have had at least three prior systemic treatments to see if the drug shrinks tumors and is tolerable.
-
Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310
This study is testing a new treatment called SynKIR-310 to see if it can help adults with relapsed or refractory B-cell lymphoma feel better.
Related topics
Quick answers
How many Follicular Lymphoma Grade 3 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.